Peter Tipping Selected Research

B-Cell Activation Factor Receptor

2/2017	Opposing roles of B lymphocyte subsets in atherosclerosis.
1/2013	BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice.
1/2012	Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Tipping Research Topics

Disease

16	Atherosclerosis 01/2018 - 10/2010
6	Inflammation (Inflammations) 11/2017 - 04/2005
3	Myocardial Infarction 11/2017 - 02/2016
3	Stroke (Strokes) 11/2017 - 02/2016
3	Necrosis 02/2016 - 11/2002
2	Infections 12/2017 - 11/2017
2	Autoimmune Diseases (Autoimmune Disease) 11/2017 - 11/2015
2	Fibrosis (Cirrhosis) 08/2017 - 03/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2017 - 03/2012
2	Atherosclerotic Plaque (Atheroma) 03/2013 - 03/2002
2	Body Weight (Weight, Body) 01/2012 - 09/2011
2	Arthritis (Polyarthritis) 04/2005 - 01/2004
1	Rupture 02/2017
1	IgG Deficiency 11/2015
1	Hypertension (High Blood Pressure) 11/2015
1	Vascular Remodeling 11/2015
1	Arteritis 01/2012
1	Hyperlipidemias (Hyperlipidemia) 10/2010
1	Hypersensitivity (Allergy) 01/2004
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2002
1	Septic Shock (Toxic Shock Syndrome) 01/2002
1	Sepsis (Septicemia) 01/2002
1	Multiple Organ Failure (MODS) 01/2002

Drug/Important Bio-Agent (IBA)

10	Apolipoproteins E (ApoE)IBA 02/2016 - 03/2002
7	CytokinesIBA 01/2018 - 01/2002
5	ApolipoproteinsIBA 01/2015 - 03/2002
4	Immunoglobulin M (IgM)IBA 02/2017 - 09/2011
4	LipidsIBA 02/2016 - 10/2010
3	Immunoglobulin G (IgG)IBA 01/2018 - 11/2015
3	B-Cell Activation Factor ReceptorIBA 02/2017 - 01/2012
3	AntibodiesIBA 11/2015 - 01/2013
3	PerforinIBA 01/2015 - 03/2013
3	Granzymes (Granzyme)IBA 01/2015 - 03/2013
3	Monoclonal AntibodiesIBA 03/2013 - 09/2012
3	InterleukinsIBA 03/2013 - 01/2002
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2012
2	Thromboplastin (Tissue Factor)IBA 08/2017 - 01/2004
2	Proteinase-Activated ReceptorsIBA 08/2017 - 04/2005
2	Hydroxyproline (4 Hydroxyproline)IBA 08/2017 - 03/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2017 - 02/2016
2	CholesterolIBA 02/2017 - 10/2011
2	oxidized low density lipoproteinIBA 02/2017 - 11/2016
2	InterferonsIBA 01/2015 - 03/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013 - 01/2002
2	CollagenIBA 03/2012 - 09/2011
2	methylated bovine serum albumin (MBSA)IBA 04/2005 - 01/2004
2	AntigensIBA 04/2005 - 01/2004
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	ChemokinesIBA 11/2017
1	Cytotoxins (Cytolysins)IBA 11/2017
1	C.I. direct red 80IBA 08/2017
1	Therapeutic UsesIBA 02/2017
1	tesmilifene (DPPE)IBA 02/2016
1	AllergensIBA 02/2016
1	phosphorylethanolamine (phosphoethanolamine)IBA 02/2016
1	Angiotensin IIIBA 11/2015
1	Liposomes (Liposome)IBA 06/2015
1	PhosphatidylserinesIBA 06/2015
1	interleukin-21 (interleukin 21)IBA 01/2015
1	Interleukin-4 (Interleukin 4)IBA 01/2015
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2013
1	Interleukin-2 (IL2)IBA 09/2012
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2012
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2012
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 03/2012
1	PAR-2 ReceptorIBA 03/2012
1	Cytokine Receptors (Cytokine Receptor)IBA 10/2010
1	Thrombin FDA Link 04/2005
1	Plasminogen Activator Inhibitor 1IBA 03/2002
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2002
1	Complement System Proteins (Complement)IBA 01/2002
1	AnaphylatoxinsIBA 01/2002
1	P-30 composite resin (P 30)IBA 01/2002

Therapy/Procedure

4	Therapeutics 11/2017 - 10/2011
2	Intra-Articular Injections 04/2005 - 01/2004
1	Immunomodulation 12/2017
1	Immunotherapy 11/2017
1	Splenectomy 06/2015
1	Hemofiltration 01/2002